XML 43 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
Reverse Recapitalization (Tables)
6 Months Ended
Jun. 30, 2022
Reverse Recapitalization [Abstract]  
Summary of Business Acquisition Elements Reconciled To Consolidated Financial Statements The following table reconciles the elements of the Business Combination to the condensed consolidated statements of cash flows and the condensed consolidated statements of stockholders’ equity for the six months ended June 30, 2022 (in thousands):
Cash - CCAC’s trust and cash (net of redemption)
   $ 13,414  
Cash - PIPE
     36,950  
Less: transaction costs and advisory fees paid
     (6,609
  
 
 
 
Net cash from Business Combination and PIPE Financing
     43,755  
Less
non-cash
net liabilities assumed from CCAC
     (15,955
  
 
 
 
Net contributions from Business Combination and PIPE Financing
   $ 27,800  
  
 
 
 
Summary of Number of Shares of Common Stock Issued Immediately Following The Consummation of The Business Combination
The number of shares of common stock issued immediately following the consummation of the Business Combination were:
 
CCAC Class A Ordinary Shares, outstanding prior to Business Combination
     27,600,000  
CCAC Class B Ordinary Shares, outstanding prior to Business Combination
     6,900,000  
Less: redemption of CCAC Class A Ordinary Shares
     (26,267,796
Shares issued from PIPE Financing
     3,695,000  
  
 
 
 
Total Shares from Business Combination and PIPE Financing
     11,927,204  
Legacy Quanergy shares
(1)
     71,485,143  
  
 
 
 
Total shares of common stock immediately after Business Combination
     83,412,347  
  
 
 
 
Summary of Number of Legacy Quanergy Shares The number of Legacy Quanergy shares was determined as follows:
    
Quanergy
shares
    
Quanergy
shares,
effected for
Exchange
Ratio
 
Balance at December 31, 2020
     4,696,352        18,221,534  
Recapitalization applied to Convertible Preferred Stock outstanding at December 31, 2020
     7,695,112        37,548,022  
Shares issued upon exercise of options - 2021
     20,000        77,595  
Shares issued upon exercise of common stock warrants - 2021
     2,324        9,016  
Issuance of restricted stock awards
     300,000        1,163,984  
Conversion of 2023 Notes
(2)
     3,728,147        14,464,992  
     
 
 
 
Total
        71,485,143